Skip to content

Vitrification Versus Spontaneous Conception and Slow- Rate Freezing

Maternal Pregnancy and Neonatal Outcome After Assisted Reproduction. Comparison of Vitrification vs. Spontaneous Conception

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01088425
Enrollment
850
Registered
2010-03-17
Start date
2010-03-31
Completion date
2015-12-31
Last updated
2017-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

vitrification, 2PN oocyte, maternal and infant health, embryo survival, clinical pregnancy rate, mode of delivery, injury during delivery, infant development, infant morbidity, slow- rate freezing

Brief summary

Great scientific effort has been made to improve practical as well as economical procedures of modern assisted reproduction. In the last years a shift from the well established method of slow-rate freezing to vitrification of 2PN zygotes and embryos could be observed. Like any other method of cryopreservation, the outcome of vitrification will be affected by several factors related to technique itself, its practical management and patient characteristics. The investigators want to investigate the influence of vitrification on the outcome of of 2PN oocytes, pregnancy and infant health. A Comparison between a cohort of spontaneous conceived children and children of vitrified and slow- cooled 2PN oocytes is planned.

Interventions

OTHERObservation

Alberta infant motor scale Griffiths test Kauffmann ABC

Sponsors

University of Luebeck
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* cryopreservation (vitrification and slow- rate freezing) between 1998 - 2010 * Treatment in Lübeck University * Delivery in Lübeck University * Positive informed consent

Exclusion criteria

* Negative informed consent

Design outcomes

Primary

MeasureTime frameDescription
Maternal pregancy outcome7 yearsspontaneous or operative delivery, birth injuries, conjoined morbidity
embryo survival7 yearsembryo survival rate

Secondary

MeasureTime frameDescription
infant health7 yearsinfant vital characteristics (APGAR, arterial cord ph), infant development: only develomental milestones: sitting, standing, walking infant morbidity

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026